» Articles » PMID: 856024

Bacteriocin Production by Strains of Bacteroides Isolated from Human Feces and the Role of These Strains in the Bacterial Ecology of the Colon

Overview
Specialty Pharmacology
Date 1977 Apr 1
PMID 856024
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Several human fecal isolates of Bacteroides have been found to produce bacteriocins. The bacteriocin-producing strain T1-1 was studied in the most detail. Strain T1-1 belongs to the 0061-1 deoxyribonucleic acid (DNA) homology group of Bacteroides. This homology group phenotypically resembles Bacteroides thetaiotaomicron but has little DNA homology with it. The bacteriocin-producing strains T1-12 and T1-48 belong to the 3452-A DNA homology group. This group has DNA homology with B. thetaiotaomicron and Bacteroides ovatus. The bacteriocin-producing strain T1-42 remains unidentified in that it does not belong to any recognized DNA homology group of the saccharolytic intestinal bacteroides. The extracellular bacteriocin produced by strain T1-1 was specifically bactericidal for other bacteria within the genus Bacteroides. The highest bacteriocin titers (32 to 64) were produced in complex media, with only trace amounts being produced in a defined medium. The bacteriocin appeared to have a high molecular weight (>/=300,000) and was unusual because it was stable from pH 1 to 12 and only a 50% reduction in activity resulted after 15 min at 121 degrees C in an autoclave. It was inactivated by trypsin and Pronase. Strain T1-1 was isolated from all three fecal samples obtained over a 25-week period from an individual who was part of a National Aeronautics and Space Administration mock Skylab flight. Strains T1-12, T1-48, and T1-42 were isolated only from the first fecal sample. Each of these strains was immune to the bacteriocins produced by the others. These strains were found to coexist in the colon with a larger population of non-bacteriocin-producing, bacteriocin-susceptible strains of Bacteroides.

Citing Articles

Gut Distribution, Impact Factor, and Action Mechanism of Bacteriocin-Producing Beneficial Microbes as Promising Antimicrobial Agents in Gastrointestinal Infection.

Peng Z, Wang D, He Y, Wei Z, Xie M, Xiong T Probiotics Antimicrob Proteins. 2024; 16(5):1516-1527.

PMID: 38319538 DOI: 10.1007/s12602-024-10222-6.


First characterization of the probiotic potential of lactic acid bacteria isolated from Costa Rican pineapple silages.

Wen Fang Wu Wu J, Redondo-Solano M, Uribe L, WingChing-Jones R, Usaga J, Barboza N PeerJ. 2021; 9:e12437.

PMID: 34909269 PMC: 8641478. DOI: 10.7717/peerj.12437.


In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project's reference genome database.

Walsh C, Guinane C, Hill C, Ross R, OToole P, Cotter P BMC Microbiol. 2015; 15:183.

PMID: 26377179 PMC: 4573289. DOI: 10.1186/s12866-015-0515-4.


Antagonistic activity expressed by Shigella sonnei: identification of a putative new bacteriocin.

Bernardes Sousa M, Farias L, de Oliveira P, Moreira J, Apolonio A, Oliveira J Mem Inst Oswaldo Cruz. 2013; 108(6):724-9.

PMID: 24037194 PMC: 3970690. DOI: 10.1590/0074-0276108062013008.


The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics.

Suarez J, Edwards A, McBride S J Bacteriol. 2013; 195(11):2621-31.

PMID: 23543720 PMC: 3676062. DOI: 10.1128/JB.00166-13.


References
1.
BEERENS H, Baron G . [DEMONSTRATION OF BACTERIOCINS ELABORATED BY ANAEROBIC GRAM NEGATIVE BACTERIA BELONGING TO THE EGGERTHELLA GENUS]. Ann Inst Pasteur (Paris). 1965; 108:255-6. View

2.
SEARS H, BROWNLEE I, UCHIYAMA J . Persistence of individual strains of Escherichia coli in the intestinal tract of man. J Bacteriol. 1950; 59(2):293-301. PMC: 385752. DOI: 10.1128/jb.59.2.293-301.1950. View

3.
SEARS H, Janes H, Saloum R, BROWNLEE I, LAMOREAUX L . Persistence of individual strains of Escherichia coli in man and dog under varying conditions. J Bacteriol. 1956; 71(3):370-2. PMC: 357805. DOI: 10.1128/jb.71.3.370-372.1956. View

4.
Vieu J . [APPLICATIONS OF BACTERIOCINOGENY AND BACTERIOCINS]. Ann Inst Pasteur (Paris). 1964; 107:SUPPL:93-114. View

5.
BRANCHE Jr W, YOUNG V, ROBINET H, Massey E . EFFECT OF COLICINE PRODUCTION ON ESCHERICHIA COLI IN THE NORMAL HUMAN INTESTINE. Proc Soc Exp Biol Med. 1963; 114:198-201. DOI: 10.3181/00379727-114-28624. View